{"id":"betablocker-titration","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Fatigue"},{"rate":"5-15","effect":"Bradycardia"},{"rate":"5-10","effect":"Hypotension"},{"rate":"5-10","effect":"Dizziness"},{"rate":"2-5","effect":"Dyspnea"},{"rate":"5-10","effect":"Erectile dysfunction"},{"rate":"1-3","effect":"Bronchospasm (in susceptible patients)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Beta-blockers competitively antagonize epinephrine and norepinephrine at beta-1 and beta-2 adrenergic receptors. This reduces sympathetic nervous system activity, leading to decreased cardiac output, heart rate, and myocardial oxygen demand. They are used to manage hypertension, angina, arrhythmias, and heart failure by titrating the dose to achieve target hemodynamic parameters.","oneSentence":"Beta-blockers inhibit the effects of catecholamines on beta-adrenergic receptors, reducing heart rate, contractility, and blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:40:10.702Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Angina pectoris"},{"name":"Arrhythmias (including atrial fibrillation)"},{"name":"Heart failure"},{"name":"Post-myocardial infarction management"}]},"trialDetails":[{"nctId":"NCT05637853","phase":"PHASE4","title":"Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Göteborg University","startDate":"2022-10-22","conditions":"Heart Failure With Reduced Ejection Fraction","enrollment":60},{"nctId":"NCT05066971","phase":"NA","title":"Rate Control Self-adjustment in Patients With Permanent or Persistent Atrial Fibrillation Using Device Home Monitoring","status":"UNKNOWN","sponsor":"Université de Sherbrooke","startDate":"2022-07-01","conditions":"Atrial Fibrillation, Persistent","enrollment":50},{"nctId":"NCT01868880","phase":"PHASE4","title":"Effect of Ivabradine and Beta-blockers Combination Versus Beta-blockers Up-titration on Right Ventricular Pacing","status":"WITHDRAWN","sponsor":"Policlinico Casilino ASL RMB","startDate":"2016-02","conditions":"Heart Rate Control in ICD Patients With Heart Failure","enrollment":""},{"nctId":"NCT00562952","phase":"PHASE2, PHASE3","title":"Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2007-11","conditions":"Diabetes Mellitus, Heart Failure, Coronary Artery Disease","enrollment":300}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":487,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"betablocker titration","genericName":"betablocker titration","companyName":"Policlinico Casilino ASL RMB","companyId":"policlinico-casilino-asl-rmb","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Beta blockers are used to treat conditions such as diabetes mellitus, heart failure, coronary artery disease, atrial fibrillation, and heart rate control in ICD patients with heart failure. They are small molecule medications that work by modulating the activity of nicotinic acid.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}